Dong Zhang

dong1

ALT therapeutics

2019-2020

Affiliations

New York Institute of Technology

Technologies

Therapeutic

Indication

Oncology

We discovered that inhibition of FANCM prevents the survival of ALT cancers (10-15% of cancers) and planned to develop FANCM inhibitors to treat ALT cancers.

Newsletter Signup

Corporate Supporters

Community Service Providers